T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine

被引:328
作者
Kobie, James J.
Shah, Pranav R.
Yang, Li
Rebhahn, Jonathan A.
Fowell, Deborah J.
Mosmann, Tim R.
机构
[1] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA
关键词
D O I
10.4049/jimmunol.177.10.6780
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD73 (5'-ectonucleotidase) is expressed by two distinct mouse CD4 T cell populations: CD25(+) (FoxP3(+)) T regulatory (Treg) cells that suppress T cell proliferation but do not secrete IL-2, and CD25(-) uncommitted primed precursor Th (Thpp) cells that secrete IL-2 but do not suppress in standard Treg suppressor assays. CD73 on both Treg and Thpp cells converted extracellular 5'-AMP to adenosine. Adenosine suppressed proliferation and cytokine secretion of Th1 and Th2 effector cells, even when target cells were activated by anti-CD3 and anti-CD28. This represents, an additional suppressive mechanism of Treg cells and a previously unrecognized suppressive activity of Thpp cells. Infiltration of either Treg or Thpp cells at inflammatory sites could potentially convert 5'-AMP generated by neutrophils or dying cells into the anti-inflammatory mediator adenosine, thus dampening excessive immune reactions.
引用
收藏
页码:6780 / 6786
页数:7
相关论文
共 60 条
  • [21] CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes
    Green, EA
    Gorelik, L
    McGregor, CM
    Tran, EH
    Flavell, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10878 - 10883
  • [22] New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency
    Hershfield, MS
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) : 25 - 30
  • [23] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061
  • [24] Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion
    Huang, S
    Apasov, S
    Koshiba, M
    Sitkovsky, M
    [J]. BLOOD, 1997, 90 (04) : 1600 - 1610
  • [25] Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-β
    Huang, XP
    Zhu, JG
    Yang, YP
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (07) : 4283 - 4291
  • [26] Cutting edge:: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+ CD25+ T cells
    Huber, S
    Schramm, C
    Lehr, HA
    Mann, A
    Schmitt, S
    Becker, C
    Protschka, M
    Galle, PR
    Neurath, MF
    Blessing, M
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (11) : 6526 - 6531
  • [27] Migration and function of antigen-primed nonpolarized T lymphocytes in vivo
    Iezzi, G
    Scheidegger, D
    Lanzavecchia, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) : 987 - 993
  • [28] Inflammatory cytokines regulate function and expression of adenosine A2A receptors in human monocytic THP-1 cells
    Khoa, ND
    Montesinos, MC
    Reiss, AB
    Delano, D
    Awadallah, N
    Cronstein, BN
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (07) : 4026 - 4032
  • [29] Memory of extracellular adenosine A(2A) purinergic receptor-mediated signaling in murine T cells
    Koshiba, M
    Kojima, H
    Huang, S
    Apasov, S
    Sitkovsky, MV
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) : 25881 - 25889
  • [30] TGF-β1 production by CD4+CD25+ regulatory T cells is not essential for suppression of intestinal inflammation
    Kullberg, MC
    Hay, V
    Cheever, AW
    Mamura, M
    Sher, A
    Letterio, JJ
    Shevach, EM
    Piccirillo, CA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (10) : 2886 - 2895